10 Best Fortune 500 Stocks To Buy Now
The aggregate revenue of the Fortune 500 companies in 2023 reached a record $41 trillion, up 0.1% year-over-year. Profits also rose 2% after declining earlier in 2022.
Cvs Health Corp (CVS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Pzena Investment Management Richard S. Pzena | 12,936,388 | $764,023,075 | +133% | 2.68% |
| 2. | Glenview Capital Larry Robbins | 9,162,389 | $541,130,694 | +441% | 10.65% |
| 3. | AQR Capital Management Cliff Asness | 5,289,788 | $310,722,127 | +34% | 0.47% |
| 4. | Harris Associates Natixis Global Asset Management | 4,728,403 | $279,259,483 | +10% | 0.47% |
| 5. | 4,378,600 | $258,600,116 | -1% | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $53.88 | 1,000 | Director | 21,630 | 2024-05-02 | Filing | |
| $54.49 | 9,181 | Director | 9,356 | 2024-05-02 | Filing | |
| $70.47 | 2,000 | Director | 20,630 | 2023-11-03 | Filing | |
| $69.75 | 14,000 | Officer, Director | 431,392 | 2023-05-03 | Filing | |
| $105.90 | 1,000 | Director | 18,334 | 2022-02-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $76.95 | 29,473 | Officer | 39,765 | 2024-02-16 | Filing | |
| $74.94 | 23,128 | Officer | 4,698 | 2023-08-03 | Filing | |
| $74.79 | 2,631 | Officer | 27,826 | 2023-08-03 | Filing | |
| $98.24 | 36,490 | Officer | 608,129 | 2022-12-15 | Filing | |
| $98.40 | 100,976 | Officer | 608,129 | 2022-12-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 117,696,222 | $9,293,293,688 | 0.2% | |
| 2. | 87,022,999 | $6,871,335,995 | 0.17% | |
| 3. | 55,203,124 | $4,358,838,671 | 0.21% | |
| 4. | 40,544,702 | $3,201,410,461 | 0.56% | |
| 5. | 37,818,784 | $2,986,171,215 | 0.22% |
News See All
10 Best Beaten Down Dividend Stocks to Invest in Now
Dividend stocks have faced challenges over the past year due to the rising focus on tech stocks. However, the value of income remains strong, and investors haven't overlooked dividend equities.
Should You Hold CVS Health Corporation (CVS)?
Ariel Investments, an investment management company, released its “Ariel Global Fund” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Weaker Earnings Report Dragged CVS Health Corporation (CVS)
Invesco Distributors, Inc., an investment management firm, released its “Invesco Growth and Income Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
CVS Health Corporation (NYSE:CVS) Q2 2024 Earnings Call Transcript
Operator: Good morning or good afternoon all and welcome to the CVS Health Q2 2024 earnings conference call. My name is Adam and I’ll be your Operator today.
The Highest Paying Medical Job In The US
The healthcare industry is a vast and multifaceted sector that includes hospitals, nursing homes, private practices, research institutions, and pharmaceutical companies.
10 Best Health Insurance Stocks to Buy
2023 posed significant challenges for the healthcare sector as investors adjusted their portfolios to adapt to a higher interest rate environment.
Several Headwinds Pulled CVS Health Corporation (CVS) Down in Q2
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Here’s Why CVS Health Corporation (CVS) Slipped in Q2
ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Value Strategy” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Here’s Why Vltava Fund Sold Its Stake in CVS Health Corporation (CVS)
Vltava Fund, an investment management company, recently released its second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Billionaire Hedge Funds
